Mark Y. Jeong

1.6k total citations
23 papers, 1.1k citations indexed

About

Mark Y. Jeong is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Mark Y. Jeong has authored 23 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Cardiology and Cardiovascular Medicine and 6 papers in Surgery. Recurrent topics in Mark Y. Jeong's work include Signaling Pathways in Disease (7 papers), Cardiomyopathy and Myosin Studies (7 papers) and Tissue Engineering and Regenerative Medicine (5 papers). Mark Y. Jeong is often cited by papers focused on Signaling Pathways in Disease (7 papers), Cardiomyopathy and Myosin Studies (7 papers) and Tissue Engineering and Regenerative Medicine (5 papers). Mark Y. Jeong collaborates with scholars based in United States, Italy and Germany. Mark Y. Jeong's co-authors include Timothy A. McKinsey, Carlin S. Long, Koichiro Kinugawa, Maria A. Cavasin, Kunhua Song, Peter M. Buttrick, Yuanbiao Zhao, Lori A. Walker, Yingqiong Cao and Pilar Londono and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Investigation.

In The Last Decade

Mark Y. Jeong

21 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Y. Jeong United States 16 754 307 215 145 98 23 1.1k
Raisa Serpi Finland 20 521 0.7× 316 1.0× 180 0.8× 69 0.5× 82 0.8× 47 1.1k
Ki‐Chul Hwang South Korea 21 612 0.8× 138 0.4× 240 1.1× 69 0.5× 69 0.7× 45 1.2k
Katrin Streckfuß‐Bömeke Germany 20 1.0k 1.4× 524 1.7× 219 1.0× 80 0.6× 50 0.5× 56 1.5k
Christopher T. Cottage United States 15 868 1.2× 237 0.8× 397 1.8× 151 1.0× 81 0.8× 16 1.2k
Mohamed Ameen United States 15 771 1.0× 275 0.9× 212 1.0× 41 0.3× 39 0.4× 23 1.0k
João Ferreira‐Martins Portugal 12 406 0.5× 383 1.2× 378 1.8× 95 0.7× 36 0.4× 20 848
Eunhyun Choi South Korea 20 628 0.8× 87 0.3× 171 0.8× 74 0.5× 72 0.7× 42 1.1k
Valentina Sala Italy 15 448 0.6× 244 0.8× 125 0.6× 130 0.9× 82 0.8× 24 886
Maria Paola Santini United Kingdom 13 528 0.7× 177 0.6× 156 0.7× 48 0.3× 88 0.9× 21 824
Kristin M. French United States 10 720 1.0× 535 1.7× 361 1.7× 44 0.3× 65 0.7× 12 1.4k

Countries citing papers authored by Mark Y. Jeong

Since Specialization
Citations

This map shows the geographic impact of Mark Y. Jeong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Y. Jeong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Y. Jeong more than expected).

Fields of papers citing papers by Mark Y. Jeong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Y. Jeong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Y. Jeong. The network helps show where Mark Y. Jeong may publish in the future.

Co-authorship network of co-authors of Mark Y. Jeong

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Y. Jeong. A scholar is included among the top collaborators of Mark Y. Jeong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Y. Jeong. Mark Y. Jeong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jeong, Mark Y., et al.. (2023). Transthyretin Amyloid Cardiomyopathy Risk Evaluation in a Cohort of Patients With Heart Failure. The Permanente Journal. 27(2). 51–60.
2.
Lin, Ying‐Hsi, Joshua G. Travers, Sara A. Wennersten, et al.. (2022). HDAC6 modulates myofibril stiffness and diastolic function of the heart. Journal of Clinical Investigation. 132(10). 35 indexed citations
3.
Lin, Ying, William M. Schmidt, Kristofer S. Fritz, et al.. (2020). Site-specific acetyl-mimetic modification of cardiac troponin I modulates myofilament relaxation and calcium sensitivity. Journal of Molecular and Cellular Cardiology. 139. 135–147. 23 indexed citations
4.
Shettigar, Vikram, Ying‐Hsi Lin, Brendan Agatisa-Boyle, et al.. (2019). Troponin I Tyrosine Phosphorylation: Novel Regulator of Cardiac Function. Biophysical Journal. 116(3). 114a–114a. 3 indexed citations
5.
Woulfe, Kathleen C., Claudia Ferrara, Josè Manuel Pioner, et al.. (2019). A Novel Method of Isolating Myofibrils From Primary Cardiomyocyte Culture Suitable for Myofibril Mechanical Study. Frontiers in Cardiovascular Medicine. 6. 12–12. 19 indexed citations
6.
Michel, Cole R., Ying Lin, Timothy A. McKinsey, et al.. (2019). Defining decreased protein succinylation of failing human cardiac myofibrils in ischemic cardiomyopathy. Journal of Molecular and Cellular Cardiology. 138. 304–317. 38 indexed citations
7.
Odell, Aaron, et al.. (2017). Transcriptome and Functional Profile of Cardiac Myocytes Is Influenced by Biological Sex. Circulation Cardiovascular Genetics. 10(5). 32 indexed citations
8.
Peña, Brisa, Susanna Bosi, Brian A. Aguado, et al.. (2017). Injectable Carbon Nanotube-Functionalized Reverse Thermal Gel Promotes Cardiomyocytes Survival and Maturation. ACS Applied Materials & Interfaces. 9(37). 31645–31656. 51 indexed citations
9.
Peña, Brisa, Valentina Martinelli, Mark Y. Jeong, et al.. (2016). Biomimetic Polymers for Cardiac Tissue Engineering. Biomacromolecules. 17(5). 1593–1601. 35 indexed citations
10.
Pioner, Josè Manuel, Alice Ward Racca, Jordan M. Klaiman, et al.. (2016). Isolation and Mechanical Measurements of Myofibrils from Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Stem Cell Reports. 6(6). 885–896. 58 indexed citations
11.
Zhao, Yuanbiao, Pilar Londono, Yingqiong Cao, et al.. (2015). High-efficiency reprogramming of fibroblasts into cardiomyocytes requires suppression of pro-fibrotic signalling. Nature Communications. 6(1). 8243–8243. 182 indexed citations
12.
Park, Dae‐Won, Carlin S. Long, Valentina Martinelli, et al.. (2015). TEMPERATURE-RESPONSIVE MATERIALS MAY ACT AS EXTRACELLULAR MATRIX AND CELL VEHICLE FOR CARDIAC TISSUE ENGINEERING. Journal of the American College of Cardiology. 65(10). A960–A960. 1 indexed citations
13.
Demos-Davies, Kimberly, Bradley S. Ferguson, Maria A. Cavasin, et al.. (2014). HDAC6 contributes to pathological responses of heart and skeletal muscle to chronic angiotensin-II signaling. American Journal of Physiology-Heart and Circulatory Physiology. 307(2). H252–H258. 96 indexed citations
14.
Ferguson, Bradley S., Brooke C. Harrison, Mark Y. Jeong, et al.. (2013). Signal-dependent repression of DUSP5 by class I HDACs controls nuclear ERK activity and cardiomyocyte hypertrophy. Proceedings of the National Academy of Sciences. 110(24). 9806–9811. 92 indexed citations
15.
Jeong, Mark Y., et al.. (2013). Successful treatment, despite a non-surgical approach, of severe infective endocarditis. BMJ Case Reports. 2013. bcr2013201356–bcr2013201356. 1 indexed citations
16.
Lemon, Douglas D., Todd R. Horn, Maria A. Cavasin, et al.. (2011). Cardiac HDAC6 catalytic activity is induced in response to chronic hypertension. Journal of Molecular and Cellular Cardiology. 51(1). 41–50. 96 indexed citations
17.
Jeong, Mark Y., John S. Walker, R. Dale Brown, et al.. (2010). AFos inhibits phenylephrine-mediated contractile dysfunction by altering phospholamban phosphorylation. American Journal of Physiology-Heart and Circulatory Physiology. 298(6). H1719–H1726. 12 indexed citations
18.
Kinugawa, Koichiro, Mark Y. Jeong, Michael R. Bristow, & Carlin S. Long. (2005). Thyroid Hormone Induces Cardiac Myocyte Hypertrophy in a Thyroid Hormone Receptor α1-Specific Manner that Requires TAK1 and p38 Mitogen-Activated Protein Kinase. Molecular Endocrinology. 19(6). 1618–1628. 67 indexed citations
19.
Jeong, Mark Y., Koichiro Kinugawa, Charles Vinson, & Carlin S. Long. (2005). AFos Dissociates Cardiac Myocyte Hypertrophy and Expression of the Pathological Gene Program. Circulation. 111(13). 1645–1651. 33 indexed citations
20.
Kinugawa, Koichiro, Mark Y. Jeong, Atsushi Yao, et al.. (2003). Signaling Pathways Responsible for Fetal Gene Expression in the Failing Human Heart- Evidence for Altered Thyroid Hormone Receptor Gene Expression. Japanese Circulation Journal-english Edition. 67. 226. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026